LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Inicio・Lista de Acciones・Amicus Therapeutics Inc

Amicus Therapeutics Inc

Abierto

SectorSalud

10.01 1.83

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

9.93

Máximo

10.03

Métricas clave
By Trading Economics
Ingresos	42M 17M
Ventas	14M 169M
BPA	0.17
Margen de beneficio	10.237
Empleados	499
EBITDA	54M 48M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+60.89% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	706M 3.1B
Apertura anterior	8.18
Cierre anterior	10.01

Noticias sobre sentimiento de mercado

By Acuity

32%

68%

87 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

5.925 / 7.38 Soporte y Resistencia

Amicus Therapeutics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

26 nov 2025, 17:44 UTC

Ganancias

Principales Movimientos del Mercado

Deere Warns of Tough Year Ahead as Earnings, Sales Fall -- Update

27 nov 2025, 00:00 UTC

Charlas de Mercado

Rio Tinto's Coming Investor Briefing Seen Focused on Costs, Lithium, Asset Sales -- Market Talk

26 nov 2025, 23:47 UTC

Charlas de Mercado

Nikkei May Rise as Fears About Potential AI Bubble Ease -- Market Talk

26 nov 2025, 23:28 UTC

Charlas de Mercado

Mortgage Refinancing in New Zealand Will Spur Recovery -- Market Talk

26 nov 2025, 23:21 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

26 nov 2025, 23:21 UTC

Charlas de Mercado

RBNZ Rate Cuts Finally Getting Traction With Consumers -- Market Talk

26 nov 2025, 23:02 UTC

Charlas de Mercado

Steelmaking Coal Price Signal Knocked by China Import Shift -- Market Talk

26 nov 2025, 21:38 UTC

Ganancias

These Stocks Moved the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26 nov 2025, 21:25 UTC

Ganancias

Li Auto Posts Surprise Loss, Stock Rises. What's Next for Its Diving EV Sales. -- Barrons.com

26 nov 2025, 21:17 UTC

Adquisiciones, fusiones, absorciones

Commercial Metals Co Announces Closing of $2B Senior Notes Offering

26 nov 2025, 21:16 UTC

Ganancias

Deere Beat Earnings Estimates. Why the Stock Is Falling. -- Barrons.com

26 nov 2025, 21:09 UTC

Ganancias

Roblox Isn't Playing Games. Why the Stock Could -2-

26 nov 2025, 21:09 UTC

Ganancias

Roblox Isn't Playing Games. Why the Stock Could Jump 50%. -- Barrons.com

26 nov 2025, 20:27 UTC

Adquisiciones, fusiones, absorciones

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26 nov 2025, 20:25 UTC

Adquisiciones, fusiones, absorciones

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26 nov 2025, 20:15 UTC

Ganancias

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26 nov 2025, 20:08 UTC

Charlas de Mercado

Oil Futures Settle Higher in Choppy Trade -- Market Talk

26 nov 2025, 20:06 UTC

Charlas de Mercado

U.S. Natural Gas Settles Higher Ahead of Holiday -- Market Talk

26 nov 2025, 19:30 UTC

Ganancias

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26 nov 2025, 19:21 UTC

Adquisiciones, fusiones, absorciones

Teck Resources: ISS and Glass Lewis Recommend Teck Hldrs Vote for Anglo American Deal

26 nov 2025, 18:43 UTC

Charlas de Mercado

U.S. Natural Gas Storage Down for Second Straight Week -- Market Talk

26 nov 2025, 18:41 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 12 to 407 -- Market Talk

26 nov 2025, 18:19 UTC

Ganancias

Workday Beat Earnings Estimates. The Stock Is Down 10% Anyway. -- Barrons.com

26 nov 2025, 17:51 UTC

Ganancias

Deere Forecasts Higher Tariff Costs, Less Profit in 2026 -- WSJ

26 nov 2025, 17:50 UTC

Ganancias

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26 nov 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Energy & Utilities Roundup: Market Talk

26 nov 2025, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

26 nov 2025, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

26 nov 2025, 17:16 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Blue Owl Is Having a Rough Year. Its Co-CEO Says -2-

26 nov 2025, 17:16 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Blue Owl Is Having a Rough Year. Its Co-CEO Says Investors' Fears Are 'Ungrounded.' -- Barrons.com

Comparación entre iguales

Cambio de precio

Amicus Therapeutics Inc Esperado

Precio Objetivo

By TipRanks

60.89% repunte

Estimación a 12 meses

Media 15.88 USD 60.89%

Máximo 21 USD

Mínimo 11 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Amicus Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Amicus Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

5.925 / 7.38Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

87 / 374 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Amicus Therapeutics Inc

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.